EBV antivirals for treating MS
This is a short survey to test the feasibility of using natalizumab-treated patients with MS in a set of experimental medicine trials to see whether or not MS disease activity is driven by active EBV infection.
Sign in to Google to save your progress. Learn more
How best would you describe yourself? *
Next
Clear form
Never submit passwords through Google Forms.
This form was created inside of Gavin Giovannoni. Report Abuse